By Daniella Parra
Imperium Health and DecisionRx are teaming up to provide free Medication Therapy Optimization (MTO) to Medicare patients in Imperium’s Accountable Care Organizations (ACOs), the company said.
This program aims to enhance patient outcomes and cut healthcare costs by using DecisionRx’s pharmacogenomics-driven MTO platform to improve medication prescriptions.
DecisionRX shared results from an initial trial which showed 78% of patients received actionable medication advice from DecisionRx pharmacists and 53% needed medication changes based on pharmacist recommendations. The company said 70% had significant drug interactions, with safer alternatives suggested for 34%.
“Imperium Health is an ideal partner for DecisionRx because it shares our commitment to value-based care, and there is no denying the value – approximately $3,600 per engaged Medicare patient per year – created by Medication Therapy Optimization,” said DecisionRx CEO James Wallace. “Both organizations strive to provide next-level personalized medicine to as many patients as possible, especially those with chronic conditions.”
Contact: